Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers
暂无分享,去创建一个
Jan Lubinski | Charis Eng | Ping Sun | Barry Rosen | Peter Ainsworth | William Foulkes | D. Horsman | W. Foulkes | B. Weber | C. Isaacs | J. Lubiński | E. Friedman | N. Tung | B. Rosen | C. Eng | A. Eisen | S. Narod | J. Kotsopoulos | H. Lynch | P. Ainsworth | P. Sun | P. Ghadirian | C. Kim-sing | Henry Lynch | Andrea Eisen | Claudine Isaacs | Eitan Friedman | Nadine Tung | Steven A Narod | Parviz Ghadirian | Charmaine Kim-Sing | Barbara Weber | Douglas Horsman | Joanne Kotsopoulos | André Nkondjock | A. Nkondjock | E. Friedman
[1] D. Bishop,et al. Breast and Ovarian Cancer Incidence in BRCA I -Mutation Carriers , 2007 .
[2] S. Kuriyama,et al. Coffee consumption and the risk of primary liver cancer: Pooled analysis of two prospective studies in Japan , 2005, International journal of cancer.
[3] M. Inoue,et al. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. , 2005, Journal of the National Cancer Institute.
[4] S. Narod,et al. Towards a dietary prevention of hereditary breast cancer. , 2005, Cancer causes & control : CCC.
[5] S. Narod,et al. Brief Report: Towards a dietary prevention of hereditary breast cancer , 2005, Cancer Causes & Control.
[6] Abelardo Avila Curiel. Food, nutrition and the prevention of cancer: a global perspective , 2004 .
[7] D. Horsman,et al. Smoking and the risk of breast cancer among carriers of BRCA mutations , 2004, International journal of cancer.
[8] I. Rowland,et al. Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer , 2004, British Journal of Nutrition.
[9] V. Speirs,et al. Phyto-oestrogens and breast cancer chemoprevention , 2004, Breast Cancer Research.
[10] E. John,et al. Sources of Phytoestrogen Exposure among Non-Asian Women in California, USA , 2000, Cancer Causes & Control.
[11] N. Boyd,et al. Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study , 2004, Breast Cancer Research.
[12] T. Klug,et al. Predictors of the plasma ratio of 2-hydroxyestrone to 16alpha-hydroxyestrone among pre-menopausal, nulliparous women from four ethnic groups. , 2003, Carcinogenesis.
[13] X. Shu,et al. Urinary estrogen metabolites and breast cancer: differential pattern of risk found with pre- versus post-treatment collection , 2003, Steroids.
[14] F. Couch,et al. Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. , 2002, Journal of the National Cancer Institute.
[15] J. Satagopan,et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. , 2002, The New England journal of medicine.
[16] Susan L Neuhausen,et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. , 2002, The New England journal of medicine.
[17] R. S. Lord,et al. Estrogen metabolism and the diet-cancer connection: rationale for assessing the ratio of urinary hydroxylated estrogen metabolites. , 2002, Alternative medicine review : a journal of clinical therapeutic.
[18] Alicja Wolk,et al. Coffee, tea, and caffeine consumption and breast cancer incidence in a cohort of Swedish women. , 2002, Annals of epidemiology.
[19] S. Narod. Hormonal Prevention of Hereditary Breast Cancer , 2001, Annals of the New York Academy of Sciences.
[20] K. Heimdal,et al. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study , 2000, The Lancet.
[21] F. Berrino,et al. Estrogen Metabolism and Risk of Breast Cancer: a Prospective Study of the 2:16␣-hydroxyestrone Ratio in Premenopausal and Postmenopausal Women , 2022 .
[22] O. Olopade,et al. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. , 1999, Journal of the National Cancer Institute.
[23] V. Kataja,et al. Diet and the risk of breast cancer in a case-control study: does the threat of disease have an influence on recall bias? , 1999, Journal of clinical epidemiology.
[24] M. Osborne,et al. Phytochemicals as modulators of cancer risk. , 1999, Advances in experimental medicine and biology.
[25] F. Kadlubar,et al. Human cytochrome P4501A2. , 1999, IARC scientific publications.
[26] W. Mazur. 11 Phytoestrogen content in foods , 1998 .
[27] L. Kuller,et al. Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up. , 1998, British Journal of Cancer.
[28] H. Yamazaki,et al. Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes. , 1998, Chemical research in toxicology.
[29] G. Ho,et al. Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk. , 1998, Annals of the Academy of Medicine, Singapore.
[30] C. Nagata,et al. Association of coffee, green tea, and caffeine intakes with serum concentrations of estradiol and sex hormone-binding globulin in premenopausal Japanese women. , 1998, Nutrition and cancer.
[31] W. Mazur. Phytoestrogen content in foods. , 1998, Bailliere's clinical endocrinology and metabolism.
[32] J. Sparano,et al. Urinary estrogen metabolites and breast cancer: a case-control study. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[33] E. Barrett-Connor,et al. Caffeine intake and endogenous sex steroid levels in postmenopausal women. The Rancho Bernardo Study. , 1996, American journal of epidemiology.
[34] C. la Vecchia,et al. Influence of food groups and food diversity on breast cancer risk in Italy , 1995, International journal of cancer.
[35] M. Seller,et al. Unusual case of Smith-Lemli-Opitz syndrome "type II". , 1995, American journal of medical genetics.
[36] D. Easton,et al. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. , 1995, American journal of human genetics.
[37] T. Sellers,et al. No association between caffeine intake and postmenopausal breast cancer incidence in the Iowa Women's Health Study. , 1993, American journal of epidemiology.
[38] M. Ewertz. Breast cancer in Denmark. Incidence, risk factors, and characteristics of survival. , 1993, Acta oncologica.
[39] J. Freudenheim,et al. Diet in the epidemiology of postmenopausal breast cancer in the New York State Cohort. , 1992, American journal of epidemiology.
[40] M. Osborne,et al. Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. , 1992, Journal of the National Cancer Institute.
[41] B. Tang,et al. Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities , 1991, Clinical pharmacology and therapeutics.
[42] L. Vatten,et al. Coffee consumption and the risk of breast cancer. A prospective study of 14,593 Norwegian women. , 1990, British Journal of Cancer.
[43] G. Schreiber,et al. Confounders contributing to the reported associations of coffee or caffeine with disease. , 1988, Preventive Medicine.
[44] A. Papatestas,et al. Association of tumor differentiation with caffeine and coffee intake in women with breast cancer. , 1986, Surgery.
[45] C. la Vecchia,et al. Coffee consumption and the risk of breast cancer. , 1986, Surgery.
[46] Ivar Heuch,et al. Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study. , 1986, Journal of the National Cancer Institute.
[47] M. Lê. Coffee consumption, benign breast disease, and breast cancer. , 1985, American journal of epidemiology.
[48] B. Modan,et al. Coffee and methylxanthines and breast cancer: a case-control study. , 1985, Journal of the National Cancer Institute.
[49] D. Snowdon,et al. Coffee consumption and risk of fatal cancers. , 1984, American journal of public health.
[50] H. Bradlow,et al. Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. , 1984, The Journal of biological chemistry.
[51] J. Timson. Effect of theobromine, theophylline and caffeine on the mitosis of human lymphocytes. , 1972, Mutation research.